Data showed that patients with CRC having distant lymph node metastasis (pT stage) were significantly associated with high levels of HLA-G (p=0.028), ILT-2 (p=0.055), ILT-4 (p=0.005), and PD-L1 (p=0.064). This evidence concerns the gene LILRB2 and colorectal carcinoma.